Management Team

Karen Pignet-Aiach

Founder, Chair and CEO

Founder, Chair, and CEO of Lysogene, Ms. Karen Pignet-Aiach is also the mother of a child with MPS IIIA.

Stéphane Durant des Aulnois

Chief Financial Officer

Joined Lysogene in 2019,
he oversees the Alliance Management and Business Development departments.

Ralph Laufer

Chief Scientific Officer

Dr. Ralph Laufer is responsible for Lysogene’s scientific activities.

Marie Deneux

Chief regulatory officer

Dr. Marie Deneux is in charge of defining and executing the regulatory strategy for the development and registration…

Mark Plavsic

Chief Technical Officer

Dr. Mark Plavsic is responsible for Lysogene’ s manufacturing strategy and CMC operational development.

Sophie Olivier

Chief Medical Officer

Dr. Sophie Olivier is responsible for clinical development.

Samantha Parker

Chief Patient Access Officer

Chief Patient Access Officer Ms. Samantha Parker is Head of Lysogene’s Patient and Policy Affairs.

Michaël Hocquemiller

Head of Non-Clinical Development

Dr. Michaël Hocquemiller is in charge of the non-clinical development of Lysogene’s gene therapy products including…

Lysogene COVID-19 update

Get In Touch

Don’t hesitate to contact us if you need more help.